About Q Chip
Q Chip’s proprietary platform technology, MicroPlant™ was developed from research conducted in microfluidics at the University of Cardiff. This exclusive technology enables the precise packaging of high value fragile biological products in precision polymer microspheres. The technology has wide applications for the encapsulation of biological materials for the biopharmaceutical market in particular for biogenerics.
Investor Relations
Q Chip’s proprietary platform technology, MicroPlant™ was developed from research conducted in microfluidics at the University of Cardiff. After 4 years of intensive R&D this exclusive technology enables the precise packaging of high value fragile biological products in precision polymer microspheres. Analogous to Tetra Pak®, but at a much smaller scale (0.08mm-2mm in diameter) the technology has wide application for the encapsulation of biological materials.
Opportunities and Commercial Validation
Investors
IP
Learn more
